Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2013: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Research Abstract |
Kidney cancer cells are usually resistant to chemotherapy, therefore chemotherapy has not been a standard treatment for kidney cancer. We focused on organic aniontransporter OAT1 expressed in renal glomerular endothelial cells and involved in resorption of general drug. Our study demonstrated that OAT1 expressing kidney cancer cells exhibits increased cell death concomitant with increased incorporation of anionic cancer drug including vincristine. In vivo imaging using EGFP-OAT1 overexpressing cells was first planned, however it was abandoned due to the absense of appropriate image-capturing system.
|